Drug Fix: ALS Drug Cleared, Lecanemab’s Hopeful Alzheimer’s Data, CMS’ Price Negotiation Needs
Citeline Podcasts - Un pódcast de Citeline
Categorías:
Pink Sheet reporters and editors discuss the newly approved ALS drug Relvyrio, the promising data on the Alzheimer’s drug lecanemab, and CMS’s efforts to build the drug price negotiation program
